Fennec Pharmaceuticals introduces Pedmark, a new compound developed to reduce the incidence of hearing loss in children undergoing chemotherapy. Learn more.
Employees: 1-10
Founded date: 1996
Investors 1
| Date | Name | Website |
| - | Avoro Capi... | avorocapit... |
Mentions in press and media 18
| Date | Title | Description | Source |
| 31.01.2023 | Fennec Pharmaceuticals Announces PEDMARK® (sodium thiosulfat... | /EIN News/ -- ~ PEDMARK® is the First and Only FDA-Approved Therapy Indicated to Reduce the Risk of ... | einpresswi... |
| 17.10.2022 | Fennec Pharmaceuticals Announces Commercial Availability of ... | ~ PEDMARK is the First and Only FDA-Approved Therapy Indicated to Reduce the Risk of Cisplatin-Induc... | globenewsw... |
| 26.09.2022 | Fennec Pharmaceuticals Announces Second Closing of $20 Milli... | ~ Under the Terms of the Previously Announced Investment Agreement, $5 Million Already Funded Upon I... | globenewsw... |
| 22.08.2022 | Fennec Pharmaceuticals Closes First $5 Million Investment Fr... | ~ Under the Terms of the Investment Agreement, $5 Million to be Funded on initial closing and $20 Mi... | globenewsw... |
| 12.08.2022 | Fennec Pharmaceuticals Announces Second Quarter 2022 Financi... | ~ PEDMARKTM FDA Prescription Drug User Fee Act (PDUFA) Target Action Date Set for September 23, 2022... | globenewsw... |
| 23.05.2022 | Fennec Pharmaceuticals to Participate in Upcoming Investor C... | RESEARCH TRIANGLE PARK, N.C., May 23, 2022 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:F... | globenewsw... |
| 27.04.2022 | Fennec Pharmaceuticals Announces FDA Acceptance for Filing o... | RESEARCH TRIANGLE PARK, N.C., , April 27, 2022 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASD... | globenewsw... |
| 25.03.2022 | Fennec Pharmaceuticals to Participate in the 2022 Maxim Virt... | RESEARCH TRIANGLE PARK, N.C., March 25, 2022 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ... | globenewsw... |
| 24.03.2022 | Fennec Pharmaceuticals Resubmits New Drug Application to U.S... | RESEARCH TRIANGLE PARK, N.C., March 24, 2022 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ... | globenewsw... |
| 31.01.2022 | Fennec Pharmaceuticals Announces Management Change | RESEARCH TRIANGLE PARK, N.C., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:... | globenewsw... |
Show more